Today: 10 April 2026
Visa stock dips as Trump’s 10% credit-card rate cap gains a look in Congress
14 January 2026
1 min read

Visa stock dips as Trump’s 10% credit-card rate cap gains a look in Congress

New York, January 14, 2026, 10:29 EST — Regular session

Visa Inc (V) shares dipped 0.3% to $326.85 in Wednesday’s morning session, following a sharper 4.5% drop the day before. Investors are digesting President Donald Trump’s plan to cap credit-card interest rates at 10%, along with JPMorgan execs flagging potential fallout across the sector. “Financials are getting hit by Trump’s credit-card proposal,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. Meanwhile, U.S. December consumer inflation rose 2.7% year-over-year, matching expectations and providing some support to broader markets on Tuesday. fixedincome.fidelity.com

Visa’s position in politics is crucial given its dominance in card payments. While it doesn’t rake in interest from consumer card balances, its revenue depends on the frequency of card use and the volume of transactions processed through its network.

House Speaker Mike Johnson said Congress should “think about” Trump’s proposal but cautioned about “negative secondary effects,” like lenders pulling back or lowering borrowing limits. Johnson noted that a rate cap would need legislation, responding to Trump’s call for a one-year 10% ceiling starting Jan. 20. Reuters

For now, Visa’s trading feels more like a Washington headline than a reflection of payments growth. If lenders start tightening credit or cutting rewards to safeguard profits, payment volumes could drop fast, with fewer purchases and trips.

Visa unveiled a new growth angle Wednesday with a partnership alongside stablecoin infrastructure provider BVNK, aimed at boosting Visa Direct, its money-movement platform. Under the deal, select Visa Direct clients can pre-fund payouts using stablecoins — digital tokens pegged to stable assets like the U.S. dollar — and send these payouts in stablecoins in certain markets. Mark Nelsen, Visa’s global head of product for commercial and money movement solutions, highlighted that stablecoins might ease global payment friction, especially “on weekends, holidays and when banks are closed.” BVNK CEO Jesse Hemson-Struthers described stablecoins as an emerging layer of payment infrastructure. Business Wire

Some analysts say the market might be unfairly grouping Visa with lenders who actually hold the loans. Dan Dolev at Mizuho suggested a cap could push more spending toward debit cards and “buy now, pay later” schemes—installment plans at checkout—while still routing transactions through Visa and Mastercard networks. Barron’s

Wednesday saw declines among peers as well. Mastercard edged down 0.4%, American Express dipped 0.6%, and Synchrony Financial slid roughly 2.2%.

The downside is straightforward: if lawmakers push for a cap and lenders tighten credit, spending could slow, squeezing transaction growth right when the payments sector is defending its premium valuations. The longer this policy battle drags out, the more traders might drop “safe growth” stocks and shift their bets elsewhere.

Investors are waiting on specifics from the White House and Congress about how a potential cap might be structured, while also gauging if banks will pull back on card lending as earnings season progresses. Visa’s annual meeting is set for Jan. 27, according to the company’s investor site. investor.visa.com

Stock Market Today

  • West Pharmaceutical Services (WST) Valuation Assessed After Dublin Expansion
    April 10, 2026, 8:48 AM EDT. West Pharmaceutical Services (WST) unveiled a 165,000 sq ft expansion in Damastown, Dublin, boosting capacity for injectable treatments targeting diabetes and obesity. Despite a recent 7.81% share price dip over 90 days, the 1-year return stands at 16.24%, indicating gains for longer-term investors. Trading at $254.80 with an average analyst target of $316.69, WST shows signs of undervaluation according to some estimates projecting a fair value of $338.57 per share. The Dublin expansion underpins expected growth from high-margin drug delivery components and contract manufacturing. However, the price-to-earnings (P/E) ratio at 37.2x surpasses industry averages, highlighting valuation risks if market sentiment worsens. Investors face a crucial test as future earnings and margins will determine if WST can sustain its premium valuation amid softer revenue or tariff pressures.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 8:48 AM EDT West Pharmaceutical Services (WST) Valuation Assessed After Dublin Expansion April 10, 2026, 8:48 AM EDT. West Pharmaceutical Services (WST) unveiled a 165,000 sq ft expansion in Damastown, Dublin, boosting capacity for injectable treatments targeting diabetes and obesity. Despite a recent 7.81% share price dip over 90 days, the 1-year return stands at 16.24%, indicating gains for longer-term investors. Trading at $254.80 with an average analyst target of $316.69, WST shows signs of undervaluation according to some estimates projecting a fair value of $338.57 per share.
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Micron stock in focus as retail traders crowd memory names and BofA lifts target to $400
Previous Story

Micron stock in focus as retail traders crowd memory names and BofA lifts target to $400

JP Morgan stock slips after earnings as Apple Card reserve and softer deal fees linger
Next Story

JP Morgan stock slips after earnings as Apple Card reserve and softer deal fees linger

Go toTop